EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke

C. Bassetti, W. Randerath, L. Vignatelli et al.

Source: Guideline 2020
Number: 2020

Full text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Bassetti, W. Randerath, L. Vignatelli et al.. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke. Guideline 2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
ERS/EAN/ESO/ESRS Statement on the impact of sleep disorders on risk and outcome of stroke
Source: International Congress 2019 – State of the art session: Sleep and breathing disorders
Year: 2019

Does severity of obesity effect intensive care outcome of patients with obesity hypoventilation syndrome?
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012

Sleep apnoea and risk of post-operative infection: beyond cardiovascular impact
Source: Eur Respir J , 49 (4) 1700292; DOI: 10.1183/13993003.00292-2017
Year: 2017

Sleep disorder level in stroke patients and related factors
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

The diagnostic value of self-reported symptoms for the detection of sleep apnea syndrome in stroke patients
Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA
Year: 2012

Clinical characteristics and related risk factors of depression in patients with early COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Pulse-rate variability during sleep studies predicts stroke risk in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021

Obesity, sleep apnoea and COVID-19: relationship, risk and therapeutic implications
Source: Sleep and Breathing Conference 2021
Year: 2021

Menopause and cardiovascular risk factors in sleep apnea
Source: Eur Respir J 2006; 28: Suppl. 50, 200s
Year: 2006

Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2012; 39: 906-912
Year: 2012

Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006

Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002

Renal function impairment and prediction of sleep apnea in patients with high cardiovascular risk
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020

Hypoxia and cardiovascular comorbidity in the ESADA OSA patients with insomnia symptoms
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018

Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Source: Eur Respir J 2007; 29: 156-178
Year: 2007

Is obstructive sleep apnoea a risk factor for cardiovascular disease?
Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy
Year: 2005

Effect of central sleep apnoea on severity and short-term prognosis of acute coronary syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

The impact of anxiety and depression on outcomes of pulmonary rehabilitation in COPD
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011